HOME >> MEDICINE >> NEWS
Urgent action required to tackle escalating road-traffic crashes worldwide

A review in this week's issue of THE LANCET highlights how concerted action is urgently needed worldwide to tackle the global burden of injuries and deaths caused by road-traffic crashes. Attention is specifically required in low and middle-income countries where the numbers of road injuries and deaths continues to rise.

Around 1.2 million people were killed and 50 million injured in road-traffic crashes worldwide in 2002, costing the global community about US$518 billion. The International Federation of Red Cross and Red Crescent Societies has described the situation as "a worsening global disaster destroying lives and livelihoods, hampering development and leaving millions in greater vulnerability". Without appropriate action, road-traffic injuries are predicted to escalate from the ninth leading contributor to the global burden of disease in 1990 to the third by 2020.

A 2004 WHO report and the subsequent collaboration of 42 agencies worldwide led to the UN General Assembly to pass a new resolution on road safety on Oct 26, 2005. In addition to recommending the implementation of the WHO report to reduce road-traffic injuries and deaths, the UN also called for the organisation of the first UN Global Road-Safety Week (April 2326, 2007); and requested that Member States and the international community recognise the third Sunday in November of every year as the World Day of Remembrance for Road-Traffic Victims.

Associate Professor Shanthi Ameratunga (University of Auckland, New Zealand) and colleagues outline the current evidence for the severe toll that road-traffic crashes have worldwide, and emphasise the under-reported burden in low and middle-income countries.

Dr Ameratunga comments: "Motorisation has enhanced the lives of many individuals and societies. But the benefits have come with a price. Although the numbers of lives lost in road crashes in high-income countries have declined in recent decades, for most of the world's popu
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-May-2006


Page: 1 2

Related medicine news :

1. Urgent need for guidance on mobile phone use in clinical care
2. Child Survival Symposium: Urgent action needed to reduce child mortality worldwide by 2015
3. Urgent changes needed for authorisation of phase I trials
4. Urgent measures needed to tackle HIV epidemic in Moscow
5. Drug interactions with warfarin
6. States taking action to insure nations 13.3M uninsured young adults
7. Paying taxes, according to the brain, can bring satisfaction
8. CAM-oriented primary care providers result in cost savings, high patient satisfaction
9. Panel offers guidelines on skin reactions to new class of cancer drugs
10. Data showed improved quality of life and patient satisfaction with SYMBICORT
11. Chronic pain can drive you to distraction

Post Your Comments:
(Date:8/21/2014)... 2014 The employees of Pharmica ... Washington Crossing, Pennsylvania on Thursday, August 7th to spend ... been looking for different ways that Pharmica could get ... with Pharmica Consulting. “When we heard that we could ... we jumped at the opportunity.” , Pharmica spent their ...
(Date:8/21/2014)... 21, 2014 Sometimes you have to lose the ... new book “From Zero to a Hundred: Finding My Purpose through ... story of surviving a broken family, a childhood of gang violence ... who you were created to be,” Roy said. “I didn’t give ... I know my purpose today of helping others overcome their trials.” ...
(Date:8/21/2014)... Michael E. Steuer , local doctor in ... the Bluff City with recent philanthropy at local synagogue. “The ... United States,” says friend and Rabbi David Julian of Or ... as providing in-house for the needy and teaching Hebrew to ... the local synagogue. And to remain close with the development ...
(Date:8/21/2014)... Drake University’s Phi Gamma Delta (FIJI) and ... cancer research, according to Billy Cundiff, President of Colleen’s ... for the Cleveland Browns, says the money raised by ... Dream Foundation and will fund research to be conducted ... Division of Gynecologic Oncology at the University of Iowa’s ...
(Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous ... new range of hand scraped bamboo floorings ... an Autumn special offer for these elegant items. According ... a discounted price, up to 25% off; the promotion ... , Providing natural looks and available in different varieties, ...
Breaking Medicine News(10 mins):Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
(Date:8/20/2014)... DIEGO , Aug. 20, 2014 Trovagene, ... diagnostics, announced today that results from two clinical studies ... conference for the Company,s urine-based diagnostic test for the ... The IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. ...
(Date:8/20/2014)... Phase I Trial of Plasma ... KalVista Pharmaceuticals ("KalVista"), an ophthalmology company with a ... it has begun a Phase I, First in Human, ... the treatment of DME. The study,s Principal Investigator is ... Joslin Diabetes Center; Harvard Medical School Department of Ophthalmology, ...
Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
Cached News: